| ICD-10-CM-2023 > E00-E89 > E15-E16 > E16 |
E15-E16 | Other disorders of glucose regulation and pancreatic internal secretion | |
E16 | Other disorders of pancreatic internal secretion | |
E16.0 | Drug-induced hypoglycemia without coma | |
Excl1.: | diabetes with hypoglycemia without coma (E09.649) | |
Use add'l | code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) | |
E16.1 | Other hypoglycemia | |
Info: | Functional hyperinsulinism Functional nonhyperinsulinemic hypoglycemia Hyperinsulinism NOS Hyperplasia of pancreatic islet beta cells NOS | |
Excl1.: | diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649) hypoglycemia in infant of diabetic mother (P70.1) neonatal hypoglycemia (P70.4) | |
E16.2 | Hypoglycemia, unspecified | |
Excl1.: | diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649) | |
E16.3 | Increased secretion of glucagon | |
Info: | Hyperplasia of pancreatic endocrine cells with glucagon excess | |
E16.4 | Increased secretion of gastrin | |
Info: | Hypergastrinemia Hyperplasia of pancreatic endocrine cells with gastrin excess Zollinger-Ellison syndrome | |
E16.8 | Other specified disorders of pancreatic internal secretion | |
Info: | Increased secretion from endocrine pancreas of growth hormone-releasing hormone Increased secretion from endocrine pancreas of pancreatic polypeptide Increased secretion from endocrine pancreas of somatostatin Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptide | |
E16.9 | Disorder of pancreatic internal secretion, unspecified | |
Info: | Islet-cell hyperplasia NOS Pancreatic endocrine cell hyperplasia NOS | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |